Chongqing manufacturing company of Birdo Pharmaceutical Technology, the Shanghai headquartered high-tech CRO and CDMO group that provides integrated laboratory research and production services to pharmaceutical companies worldwide. The Chongqing operation, registered in the Tongnan district standard plant zone in March 2020, holds drug manufacturing and controlled chemical licences and supports the group's development and production work, alongside Birdo's laboratories and production bases in Shanghai, Chongqing, Xi'an and New Jersey and its offices in the United States and Europe.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét